Gliosarcoma is rare central nervous system tumour and a variant of glioblastoma multiforme with bimorphic histological pattern of glial and sarcomatous differentiation. It occurs in elderly between 5 th and 6 th decades of life and extremely rare in children. It is highly aggressive tumour and managed like glioblastoma multiforme. A 12-year-old female child presented with complaints of headache and vomiting from 15 d and blurring of vision from 3 d. Magnetic resonance imaging of brain shows heterogeneous mass in right parieto-occipital cortex. A right parieto-occipito-temporal craniotomy with complete excision of mass revealed a primary glioblastoma on histopathological investigation. Treatment consists of maximum surgical excision followed by adjuvant radiotherapy. The etiopathogenesis, treatment modalities and prognosis is discussed. The available literature is also reviewed.
Abstract
Gliosarcoma is rare central nervous system tumour and a variant of glioblastoma multiforme with bimorphic histological pattern of glial and sarcomatous differentiation. It occurs in elderly between 5 th and 6 th decades of life and extremely rare in children. It is highly aggressive tumour and managed like glioblastoma multiforme. A 12-year-old female child presented with complaints of headache and vomiting from 15 d and blurring of vision from 3 d. Magnetic resonance imaging of brain shows heterogeneous mass in right parieto-occipital cortex. A right parieto-occipito-temporal craniotomy with complete excision of mass revealed a primary glioblastoma on histopathological investigation. Treatment consists of maximum surgical excision followed by adjuvant radiotherapy. The etiopathogenesis, treatment modalities and prognosis is discussed. The available literature is also reviewed.
Key words: Paediatric gliosarcoma; Surgery; Glioblastoma multiforme; Radiotherapy
INTRODUCTION
Gliosarcoma was first time reported by Stroebe [1] . It is a rare cerebral tumour consist of bimorphic histological pattern of glial and sarcomatous differentiation. It is considered as grade 4 tumour according to WHO classification and variant of glioblastoma multiforme [2] . Incidence of gliosarcoma is 1.8%-2.8% of glioblastoma [3] . It usually affects elderly in 5 th and 6 th decades of life with slight male predominance and extremely rare in paediatric population [4] . So far only few cases of paediatric gliosarcoma have been reported. We report a case of primary gliosarcoma in 12-year-old girl.
CASE REPORT
A 12-year-old girl was admitted in our institute with history of headache and vomiting from 15 d and blurring of vision from 3 d. Her general and systemic examination was unremarkable. Neurologically Glasgow coma scale was 15/15, pupil were equal and reactive bilaterally. 
DISCUSSION
Gliosarcoma is a rare CNS tumour with incidence of 1.8%-2.8% of glioblastomas [3] . It usually occurs in elderly between 5 th and 6 th decades of life and extremely rare in paediatric population. Okami et al [5] reported eight cases of paediatric gliosarcoma, Sarkar et al [6] described three cases and Salvati et al [7] also reported three cases. Malde et al [8] reported one case of radiation induced gliosarcoma in literature.
Temporal lobe is most commonly involved followed 
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by parietal and frontal lobe and can metastasize to extracranial structures like spinal cord, lung, pleura, liver, bone marrow and lymph nodes with increased frequency as compared to gliobastomas [7] . Pathogenesis of gliosarcoma is controversial topic and various studies have been proposed. The recent theory suggests monoclonal origin of gliosarcoma. The sarcomatous component originates from aberrant mesenchymal differentiation of the malignant glial cells during tumour progression [7] . Meis et al [9] laid down the criteria's for the diagnosis of gliosarcoma on the basis of histological features: (1) the tumor should be bimorphic, and composed of two morphologically distinct populations of malignant cells (2) one component should be glial in nature with necrotic areas and must fulfil criteria adopted for defining glioblastoma (3) the sarcomatous component should resemble a spindle-cell sarcoma; and must fill one medium power field under (10 × objective with 10 × eyepiece). The computed tomography findings of gliosarcoma is extremely variable and generally these lesions appear hyperdense mass with heterogeneous thick ring enhancement surrounded by intense peritumoural edema. On magnetic resonance imaging gliosarcoma appear as heterogeneous mass lesion in T1 and T2 weighted sequences with irregular contrast enhancement and intense peritumoural edema. Management of gliosarcoma consist of maximum surgical excision followed by adjuvant radiotherapy. The role chemotherapy in gliosarcoma is still poorly defined although Morantz et al [10] reported a slight improvement in survival. The average survival in gliosarcoma after diagnosis is less than one year (6 to 14.8 mo) with few case reports of long survivors [7, 11] .
Prognosis in gliosarcoma depends on histological and radiological features of mass lesion and is slightly better in lesions with predominant sarcomatous component along with meningioma like features in radiology [7] . In conclusion, Gliosarcoma is an aggressive tumor with propensity to recur and re-grow with poor outcome. Although it occurs more commonly in the 5 th and 6 th decades of life with temporal lobe predilection, but can occur in any age group or any region. Further studies are needed to understand the biphasic nature of these tumours.
COMMENTS

Case characteristics
Patient presented with h/o of headache, vomiting and blurring of vision.
Clinical diagnosis
She was conscious with left hemiparesis (4/5 power).
Differential diagnosis
DD Includes malignant meningioma and central nervous system lymphoma and ruled out IHC marker studies.
Laboratory diagnosis
All routine blood investigations (CBC, RFT, LFT and SE) were normal.
Imaging diagnosis
Contrast-enhanced computed tomography and magnetic resonance imaging GD Brain show heterogenous mass with intense contrast enhancement surrounded by peritumoural edema.
Pathological diagnosis
HPE shows biphasic pattern of mesenchymal(spindle cells) and glial cells. 
Treatment
Microscopic complete excision of mass done. Patient was advised to attend radiotherapy clinic for adjuvant radiotherapy.
